Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Biotron Limited ( (AU:BIT) ) has shared an announcement.
Biotron Limited has announced a delay in the opening of its rights issue due to queries raised by the Australian Securities and Investments Commission (ASIC). The company now aims to open the rights issue on 17 March 2025, with the revised timetable to be confirmed soon. This delay may impact the company’s fundraising efforts and could influence its operational plans and market positioning.
More about Biotron Limited
Biotron Limited operates in the biotechnology industry, focusing primarily on the development and commercialization of novel antiviral therapies. The company is known for its innovative approach to tackling viral infections, with a particular emphasis on addressing unmet medical needs in the market.
YTD Price Performance: 390.0%
Average Trading Volume: 27,400
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $4.54M
Learn more about BIT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue